Beam therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Beam therapeutics Contact Number

Get in touch with us. 26 Landsdowne Street 2nd Floor Cambridge, MA 02139 [email protected]

Contact US: https://beamtx.com/contact/

Who is the ceo of beam therapeutics inc?

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the 39 th Annual J.P. ...

What is beam therapy?

Beam Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

What is beam dental insurance?

Beam is a smarter dental insurance company. We work with employers, individuals, and families to deliver fundamentally better care. Beam Dental

Which is lnp screening technology does beam therapeutics use?

GuideTx’s Proprietary LNP Screening Technology and Lipid Library Supports Expanded Targeting of Diverse Tissues for In Vivo Delivery of Gene Editing CAMBRIDGE, Mass., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic

Mass

21 People Used

See More ››

Beam Therapeutics Precision medicines through base editing

Data from Beam’s Novel LNP-mRNA Formulation Demonstrates In Vivo Editing in Liver Cells of Non-human Primates Up to 52% Company On-track to Submit First IND for BEAM-101 in the Second Half of 2021 CAMBRIDGE, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc.

View Contact ››

Therapeutics

37 People Used

See More ››

Beam Therapeutics Company Profile

Beam Therapeutics has 112 employees at their 1 location and $24 K in annual revenue in FY 2020. See insights on Beam Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

View Contact ››

Genetic

61 People Used

See More ››

Beam Therapeutics

Contact Email [email protected] Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases.

View Contact ››

Contact;

33 People Used

See More ››

Pioneers in the field of base editing Beam Therapeutics

Beam Therapeutics has built a values-driven organization focused on our people, advancing cutting-edge science, and rigorously developing a new class of precision genetic medicines. Contact; About Us. Our vision is to provide life-long cures to patients suffering from serious diseases.

View Contact ››

Company''s

61 People Used

See More ››

Beam Therapeutics Inc. in Cambridge, MA Company Info

Beam Therapeutics Inc. is a Massachusetts Foreign Corporation filed On March 23, 2018. The company''s File Number is listed as 001319330. The Registered Agent on file for this company is C T Corporation System and is located at 155 Federal St., Suite 700, Boston, MA 02110. The company''s principal address is 675 W. Kendall St., Cambridge, MA 02142.

View Contact ››

Corporation

62 People Used

See More ››

Beam Therapeutics Inc. in Wilmington, DE Company Info

Beam Therapeutics Inc. is a Delaware Corporation filed On January 25, 2017. The company''s File Number is listed as 6295753. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, Wilmington, DE 19801.

View Contact ››

Business

52 People Used

See More ››

Beam Therapeutics Inc. (BEAM) Company Profile & Facts

See the company profile for Beam Therapeutics Inc. (BEAM) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

View Contact ››

Recent

124 People Used

See More ››

Beam Therapeutics: Early Stage Gene Editing Company With

Beam Therapeutics is a preclinical stage biopharma with a $3.3B market cap and a recent IPO whose chart looks like this:Source. We have been observing, in recent years, these sorts of …

View Contact ››

Please leave your comments here:

Popular Brands

Bmw
Bce
Boeing
Byd
Bbva